How do.startups fundraise?

Startups fundraise by trading some combination of ownership (equity), future ownership (convertible instruments), or repayment (debt) for cash—so they can reach the next milestone that makes the company meaningfully more valuable.

If you’re a technical/medical/scientific founder, the core skill isn’t “being good at pitching.” It’s running a repeatable process: pick the right funding type for your stage, define a milestone-based plan, build a tight story + evidence, then execute outreach and closing like a project.

1) The main ways startups raise money (and when each fits)

Most fundraising paths fall into four buckets. The “right” one depends on your stage, risk profile, and how predictable your revenue is.

• Bootstrapping: You fund the company from savings, consulting, or early customer revenue. Best when you can reach meaningful traction without huge upfront costs. Upside: keep ownership. Downside: slower, more personal risk.
• Non-dilutive funding: Money that doesn’t take equity (e.g., grants, prizes, some R&D programs). Great for deep tech and science-heavy work, but timelines and eligibility vary and it can distract from customers if you’re not careful.
• Equity financing: You sell a % of the company to investors (angels or venture capital). Best when you need speed and capital to reach a big market. Downside: dilution (you own less) and investor expectations for growth.
• Debt / revenue-based financing: You borrow and repay (sometimes tied to revenue). Works best when you have predictable revenue and margins. Early-stage startups often can’t access meaningful debt without traction.

Two common “in-between” instruments:

• SAFE (Simple Agreement for Future Equity): an agreement that converts into equity later, usually at the next priced round, often with a valuation cap (max price investors pay) and/or discount (e.g., 10–20% off the next round price). Common for pre-seed.
• Convertible note: like a SAFE but structured as debt (can include interest and a maturity date). Also converts later.

2) Stages of fundraising: pre-seed, seed, Series A (what changes)

Investors don’t just buy ideas—they buy de-risking. Each stage has a different “proof” standard.

Pre-seed: prove the problem + a credible path

Typical goal: show you deeply understand the user pain, have a plausible product approach, and can build. Evidence can be strong customer discovery, prototypes, early pilots, or early revenue (varies by business).

Seed: prove early product-market fit signals

Product-market fit means the market wants your product strongly enough that growth becomes easier. At seed, you’re showing leading indicators: retention, repeat usage, revenue growth, successful pilots converting to paid, or clear technical validation plus a commercialization path.

Series A: prove a repeatable growth engine

Series A investors want a repeatable go-to-market (how you acquire customers) and evidence you can scale. You’ll be asked about unit economics (e.g., customer acquisition cost vs. lifetime value), pipeline, and hiring plan.

3) The fundraising process, step-by-step (run it like a sprint)

A clean fundraising process reduces time wasted and increases your odds. Here’s a practical sequence many founders use.

1. Pick your “next milestone”: Fundraising is easiest when the money clearly buys a value jump. Examples: “ship v1 and get 10 paying customers,” “complete a pilot with 3 hospitals,” “reach $30k MRR,” “validate manufacturing yield,” or “get regulatory pathway clarity.”
2. Decide how much to raise: Build a 12–18 month plan and cost it out. Many early-stage rounds target ~12–18 months of runway (how long until you run out of cash), but it varies. Raise enough to hit the milestone plus buffer.
3. Build your materials: You’ll typically need:
   • Pitch deck (10–15 slides): problem, solution, why now, market, traction, business model, go-to-market, competition, team, financial plan, ask.
   • One-pager: a tight summary for quick forwarding.
   • Data room: a folder with key docs (cap table, financial model, customer notes, IP summary, contracts, security/compliance notes if relevant).
4. Build a target list: Match investors to your stage and domain. A common mistake is pitching Series A firms with a pre-seed story. Aim for a list large enough to create momentum—often dozens of targets, not five.
5. Warm intros + outreach: Warm intros convert better than cold emails. Use advisors, founders, angels, accelerators, and customers. Cold outreach can work if it’s specific and evidence-based.
6. Run a tight meeting cadence: Try to cluster first meetings into a 2–4 week window. Momentum matters because investors take social proof from “others are moving.”
7. Partner meetings + diligence: If interest is real, you’ll get deeper questions: customer references, product roadmap, security, IP, hiring plan, and financials.
8. Term sheet: A term sheet is the high-level deal: valuation, amount, investor rights, board seats, etc. It’s not the final contract, but it sets the direction.
9. Close: Legal docs get signed, money wires, and you update your cap table. Expect back-and-forth.

4) What investors actually evaluate (the “why you, why now, why win” test)

Investors use different language, but most decisions reduce to a few questions:

• Market size + urgency: Is this a big enough problem, and is it painful enough that buyers act now?
• Solution advantage: Why is your approach meaningfully better (10x, not 10%)? For science/tech, translate the advantage into outcomes customers pay for (time saved, accuracy, reduced risk, cost).
• Traction: Evidence that reality agrees with your plan. Traction can be revenue, pilots, LOIs (letters of intent), retention, usage, waitlists, or technical validation—quality matters more than vanity metrics.
• Go-to-market: Who buys, how you reach them, sales cycle length, pricing, and why you can acquire customers efficiently.
• Team: Can this team execute? Domain expertise is a plus, but investors also look for speed, clarity, and ability to recruit.
• Risk map: The best founders name the top 3 risks and show a plan to retire them with the round.

If you’re coming from academia or clinical work, a useful translation is: investors want the equivalent of a strong paper—clear hypothesis, method, early results, and a credible next experiment.

5) Key fundraising terms (plain English)

These come up constantly; understanding them prevents expensive mistakes.

• Valuation: the implied value of your company. In a priced equity round, it’s usually discussed as pre-money (before investment) and post-money (after investment).
• Dilution: your ownership percentage goes down when new shares are issued. Dilution isn’t automatically bad if the round increases the company’s value and your ability to win.
• Cap table (capitalization table): who owns what (founders, employees, investors) and how many shares/options exist.
• Option pool: shares reserved for employee equity. Often negotiated in rounds.
• Runway: months until cash runs out at current burn.
• Burn: net cash spent per month.
• Lead investor: the investor who sets terms and anchors the round; others follow.

What to do next

1. Define your next fundable milestone in one sentence and list the 3–5 proof points that would convince an investor you hit it.
2. Build a 12–18 month budget (people, product, sales, compliance, overhead) and compute burn + runway; sanity-check it in /finances.
3. Create a first-pass deck (10–15 slides) and get it reviewed via /roast or compare positioning with /Competitor_study.
4. Assemble a target investor list (at least 30) segmented by stage (pre-seed/seed) and thesis; then schedule outreach in a 2–4 week sprint.
5. Practice your “two-minute story” (problem → why now → solution → traction → ask) and pressure-test it with founder examples in /interviews.